SUCCESSOR-2

Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Near Add Your Location

Sorting 21 by

  • Accepting patients
  • Show Principal Investigator
  • Not yet accepting
  • Show Principal Investigator
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
  • Accepting patients
  • Show Principal Investigator
Kaiser Permanente Orange County
Irvine Medical Center
Irvine, CA
This trial location is only accepting patients with Kaiser Permanente Insurance.
  • Accepting patients
  • Show Principal Investigator
  • Not yet accepting
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
Mitchell Cancer Institute
University of South Alabama
Mobile, AL
  • Accepting patients
  • Show Principal Investigator
116 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.